You can:
Name | 5-hydroxytryptamine receptor 2C |
---|---|
Species | Homo sapiens (Human) |
Gene | HTR2C |
Synonym | Serotonin receptor 2C serotonin 1c receptor 5-HT1C 5-HT2C 5-HT-2C [ Show all ] |
Disease | Pain Sleep initiation and maintenance disorders; Primary insomnia; Schizophrenia Unspecified Depression Drug abuse [ Show all ] |
Length | 458 |
Amino acid sequence | MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV |
UniProt | P28335 |
Protein Data Bank | 6bqg, 6bqh |
GPCR-HGmod model | P28335 |
3D structure model | This structure is from PDB ID 6bqg. |
BioLiP | BL0404805, BL0404806 |
Therapeutic Target Database | T83813 |
ChEMBL | CHEMBL225 |
IUPHAR | 8 |
DrugBank | BE0004957, BE0004881, BE0000533 |
Name | quetiapine |
---|---|
Molecular formula | C21H25N3O2S |
IUPAC name | 2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol |
Molecular weight | 383.51 |
Hydrogen bond acceptor | 5 |
Hydrogen bond donor | 1 |
XlogP | 2.1 |
Synonyms | NCGC00095911-04 2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol quetiapina 4769-EP2308867A2 SC-19077 [ Show all ] |
Inchi Key | URKOMYMAXPYINW-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 |
PubChem CID | 5002 |
ChEMBL | CHEMBL716 |
IUPHAR | 50 |
BindingDB | 50095890 |
DrugBank | DB01224 |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 3300.8 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | <1000.0 nM | MedChemComm, (2012) 3:5:580 | ChEMBL |
Ki | 615.0 nM | PMID8822531 | PDSP,BindingDB |
Ki | 1184.0 nM | PMID8997630 | PDSP,BindingDB |
Ki | 1400.0 nM | PMID18595716 | PDSP,BindingDB,ChEMBL |
Ki | 1500.0 nM | PMID11170639 | BindingDB,ChEMBL |
Ki | 1729.0 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 2000.0 nM | , None | BindingDB,ChEMBL |
Ki | 2502.0 nM | PMID12629531 | PDSP,BindingDB |
Ki | 3500.0 nM | PMID11132243 | PDSP,BindingDB |
Ki | 3820.0 nM | PMID14998318 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417